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Introduction. Outside of Wilson’s Disease, abnormal copper metabolism is a rare condition. In pregnancy, excess copper levels can
be associated with intrauterine growth restriction, preeclampsia and neurological disease. Case Report. A 32 year old Gravida 4
para 2012 with an obstetrical history complicated by elevated copper levels presented for routine prenatal care. Her children had
elevated copper levels at birth, with her ﬁrstborn child being diagnosed with autism and suﬀering three myocardial infarctions and
beingtreatedforelevatedcopperlevels.Duringherpriorpregnancies,shedeclinedtreatmentforherelevatedcopperlevels.During
this pregnancy, she had declined chelation therapy and instead choose zinc therapy. She delivered a healthy infant with normal
copper levels. Conclusion. Alterations in copper metabolism are rare, the consequences in pregnancy can be devastating. While
isolated elevations of copper in pregnancy is exceedingly rare, it is treated the same as Wilson’s disease. The goal is to prevent fetal
growth restricting and neurological sequelae in the newborn and preeclampsia in the mother. Counseling, along with treatment
options and timely delivery can greatly improve neonatal and maternal outcome.
1.Background
Isolated abnormal copper metabolism in pregnancy is a
rare condition. If left untreated, it may be associated with
developmental sequelae in the newborn. Although copper
is a trace mineral and accounts for only 0.01% of total
body weight, it plays an important role in electron trans-
port, neurotransmitter synthesis, collagen cross-linkage, and
melatonin production and is an important factor in the
coagulation cascade. Copper is absorbed by the proximal
small intestines and transported to the liver. Toxicity associ-
ated with abnormal metabolism, as seen in Wilson’s disease,
can result in excessive copper accumulation and deposition
in many tissues. This can lead to cardiac dysfunction,
liver cirrhosis, pancreatic dysfunction and neurological
abnormalities [1]. Pregnancy induces little change in the
metabolismofthistracemetal,onlyretentionintheamounts
needed for fetal growth [2]. Abnormal copper metabolism
may be associated with intrauterine fetal growth restriction,
preeclampsia, and neurological sequelae. We present a case
of unexplained abnormally elevated copper levels outside of
Wilson’s disease only during pregnancy.
2.Case
The patient is a 32-year-old gravida 4 para 2012 who
presented for routine obstetrical care at 12 weeks gestation.
Prior pregnancies were complicated by two prior cesarean
deliveries and elevated copper levels. Postpartum, her copper
levels normalized. Evaluation for Wilson’s disease, in both
the patient and her children, was negative. Her two sons,
fromdiﬀerentfathers,hadelevatedcopperlevelsatbirth.Her
ﬁrst child was diagnosed with autism and had three myocar-
dial infarctions. He is still being treated for elevated copper
levels. Her second child was diagnosed with autism and his
copper levels are now normal. During those pregnancies, the
patient declined treatment for elevations in her copper.
During the current pregnancy, copper levels were again
elevated. She was followed in the high-risk obstetrical clinic.
In the ﬁrst trimester, her copper level was 154µg/dL, the
high end of normal, with normal copper levels ranging
from 70–155µg/dL. As her pregnancy progressed, the levels
rose as high as 260µg/dL with zinc levels decreasing to
61µg/dL (normal levels of zinc range from 70–150µg/dL).
The remainder of her blood work, including liver function2 Journal of Pregnancy
tests, urine drug screens, and complete blood counts were
within normal limits. She repeatedly refused treatment with
chelationtherapy,butinsteadsheoptedtoincreaseherintake
of zinc. Following zinc supplementation of 100mg daily, her
serum zinc levels normalized to 140µg/dL. This led to a
decreased, but still elevated, copper level of 245µg/dL.
At 36 weeks, an amniocentesis was performed, which
showed lung maturity. A repeat cesarean section was
performed. She delivered a liveborn male weighing 2700
grams with Apgar scores were 9 and 9 at 1 and 5 min-
utes, respectively. Pathological examination of the placenta,
membranes and cord were negative for copper. Additional
staining for copper was also negative. The infant’s blood
copper levels and hemoglobin were within normal limits. He
showed no evidence of infection; all of his labs and physical
examinationswerenormal.Whilethyroidfunctiontestswere
normal, the baby did not have evidence of heart disease
during cardiac and NICU evaluation and workup. The
newbornhasachievedappropriatedevelopmentalmilestones
to date. Maternal serum copper levels returned to normal
during the postpartum period.
3. Discussion
Majority of copper is absorbed in the enterocytes of the
duodenum and proximal small intestine and incorporated
in the liver into apoceruloplasmin, forming ceruloplasmin.
Ceruloplasmin represents 90% of circulating copper, and
excesses are excreted into bile. Copper participates in multi-
ple enzymatic reactions with varied physiological roles from
melanin production to wound healing to electron transport.
It stimulates the absorption of iron and is required for the
synthesis and function of hemoglobin. It is also involved in
the production of elastin and collagen which contribute to
the structural stability of bone, cartilage, and tendons [1].
Wilson’s disease is an autosomal recessive disorder of
copper metabolism with a worldwide prevalence of 1:30,000
[3]. The cause of copper elevations is due to an inherited
genetic defect in the copper transport which reduces biliary
excretion. The protein responsible for copper transport from
the liver to bile is ATP7B. Mutation in the allele for this gene
leadstoabsenceordiminishedfunction,resultingindecrease
copper excretion. As the copper accumulates in the liver, it
causes liver disease and damage. Once the capacity of the
liver is exceeded, copper diﬀuses into the bloodstream and
deposits into other organs,causing damagespeciﬁcallyto the
brain, eyes, and kidneys [1]. Recent studies have shown that
during pregnancy, ATP7B plays a role in transporting copper
from the placenta to maternal circulation, thus preventing
fetal overload. If dysfunctional, excess copper remains in the
fetus and placenta leading to oxidative damage resulting in
fetal loss or damage [4].
While our patient did not have Wilson’s disease, abnor-
mal copper metabolism is a rare condition. Workup for
other causes of abnormal elevated copper metabolism were
negative in this patient; nevertheless, her treatment and
management were the same. Excess copper levels can be
associated with preeclampsia secondary to excess buildup in
theliver,andthefetuscanbecomegrowthrestrictedandhave
neurological sequelae because of oxidative damage caused
by copper accumulation in the placenta and fetal tissue
[4, 5].
There are few case reports in the literature about
successful pregnancies in women with Wilson’s disease,
probably due to hormonal changes secondary to chronic
liver disease, endocrine disorders along with infertility, and
recurrent miscarriages due to excess copper accumulation
in the uterus [3, 4]. However, patients who receive proper
treatment can conceive and have a favorable outcome in
pregnancy.
Penicillamine,trientine,tetrathiomolybdate,andzincare
drugs used for the treatment of Wilson’s disease. Penicil-
laminereducescopperlevelsbychelationandformsasoluble
complexthatisexcretedintheurine[1].Ithasbeenobserved
in more than 100 pregnancies for a variety of medical condi-
tions including rheumatoid arthritis. While the majority of
thosepregnanciesresultedinhealthynewborns,somedefects
wereobservedsuchasveinfragility,impairedwoundhealing,
cutis laxa, low-set ears, micrognathia, and hyperﬂexion of
hips and joints. Counseling and close monitoring is essential
to prevent defects in newborn and maintain eﬀective therapy
formother[3,6].Thealternative,zinc,isusuallyreservedfor
maintenance therapy; nevertheless, it appears to be equally
eﬀective as penicillamine and easily tolerated [1]. The eﬀects
of these treatments suggest that it is relatively safe during
pregnancy. However, there are too few exposed infants to be
certain.
To our knowledge, case reports of abnormal elevated
copper metabolism in pregnancy outside of Wilson’s disease
are nonexistent. Nonetheless, we treated this patient the
same,becausetheconsequencesofuntreatedWilson’sdisease
in pregnancy can lead to preeclampsia, fetal loss or fetal
growth restriction, and neurological damage. In the limited
case reports on successful pregnancies complicated by Wil-
son’s disease, penicillamine was the drug of choice and is the
mainstay of therapy, and very few case reports used zinc as
theonlytherapeuticoptionduringpregnancy.Inourpatient,
zinc therapy seems to have limited the eﬀects of excess
copper to the fetus. And while it is still too early to know
whether or not this child will develop autism or any other
neurological sequelae, zinc regimen seems to have achieved
its purpose, which is a safe maternal and neonatal outcome.
Additionally, counseling, along with treatment options and
timely delivery, can greatly improve neonatal and maternal
outcome.
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